Molecular docking
Molecular docking was performed using the CDOCKER program embedded in the Accelrys Discovery Studio 3.5 package (DS 3.5). The Pogostone structure was generated by DS 3.5, and then minimized using the CHARMM27 force field. The crystal structure of PETNR (scPDB: P71278) was used for docking. The binding site was defined to be the interaction residues Thr24, Leu26, Tyr66, Trp100, His182, Tyr184 and Tyr349; the radius was 10 Å. Automated molecular docking was performed using the "partial flexibility" CDOCKER tool in DS 3.5 in the presence of zinc cofactor. The best molecular docking results were identified based on docking scores and binding free energy. DS 3.5 was used to identify and visualize hydrogen bonds as well as hydrophobic, hydrophilic and coordination interactions with amino acid residues in the enzyme active site.
Chemistry

General Information
NMR data were obtained for 1 H at 400 MHz and for 13 C at 100 MHz, or for 1 H at 600 MHz and for 13 C at 150 MHz. Chemical shifts were reported in parts per million (ppm) using tetramethylsilane as internal standard with solvent resonance in CDCl3.
Mass spectra were recorded using electrospray ionization on a Q-TOF instrument.
Column chromatography was performed on a silica gel (200-300 mesh) using an eluent of ethyl acetate and petroleum ether. TLC was performed on glassbacked silica plates; products were visualized using UV light. Melting points were determined on a Mel-Temp apparatus.
S3
General Procedure for the Synthesis of Pogostone derivatives 3
To dehydroacetic acid 1 (50.4 mg, 0.3 mmol), amine catalyst C5 (35.9 mg, 0.06 mmol), benzoic acid (14.7mg, 0.12 mmol) and MeCN (1.5 mL) in a standard glass vial with stir bar was added α,β-unsaturated aldehyde 2 (0.36 mmol in 0.5 mL MeCN).
The reaction mixture was stirred at room temperature until the reaction was completed based on TLC. The reaction mixture was concentrated, and the residue was purified by flash chromatography on a silica gel (Petroleum ether / Ethyl Acetate = 7:1) to give the Pogostone derivatives 3 which were dried under vacuum and further analyzed by 1 H NMR, 13 C NMR and high-resolution mass spectrometry. 192.3, 183.4, 168.4, 161.2, 146.7, 143.4, 135.9, 129.6, 128.9, 127.6, 127.4, 126.3, 102.6, 99.3, 20.6 207.6, 192.7, 181.7, 169.1, 160.8, 152.8, 141.5, 141.3, 139.9, 128.6, 128.4, 128.3, 127.6, 126.8, 126.7, 101.7, 99.7, 53.0, 40.0, 36.7, 31.1, 20 .6 ppm. HRMS (ESI): m/z calculated for C26H22O5+Na:
4-hydroxy-6-methyl-3-((2E
437.1365, found: 437.1364. 192.3, 183.3, 168.6, 161.2, 146.1, 138.5, 134.4, 133.9, 130.3, 130.1, 129.5, 127.4, 127.1, 127.0, 102.5, 99.4, 20.6 192.3, 183.3, 168.6, 161.2, 145.7, 141.3, 137.8, 134.9, 130.1, 129.3, 128.7, 127.4, 127.4, 125.6, 102.5, 99.4, 20.6 192.3, 183.3, 168.5, 161.2, 146.1, 141.7, 134.9, 132.1, 128.9, 128.0, 127.0, 123.6, 102.5, 99.4, 20.6 192.2, 183.4, 168.3, 161.2, 147.2, 143.7, 140.0, 133.3, 129.7, 127.6, 126.5, 125.7, 102.6, 99.3, 21.3, 20 .6 ppm. HRMS (ESI): m/z calculated for C18H16O4+Na: 319.0946, found: 319.0941. 192.2, 183.5, 168.2, 161.3, 157.8, 148.2, 139.0, 130.9, 128.1, 128.0, 125.4, 124.9, 120.8, 111.1, 102.7, 99.3, 55.5, 20.6 ppm. HRMS (ESI): m/z calculated for C18H16O5+Na: 335.0895, found: 335.0897. 147.5, 143.5, 129.3, 128.8, 125.4, 125.0, 114.4, 114.4, 102.7, 99.2, 55.4, 20.6 ppm.
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HRMS ( 192.0, 183.4, 168.3, 161.2, 152.3, 146.3, 144.4, 129.5, 126.1, 125.8, 113.2, 112.5, 102.6, 99.3, 20.6 5, 180.6, 168.9, 160.4, 140.9, 124.4, 101.3, 100.2, 51.1, 37.3, 30.8, 22.4, 22.3, 20.7 
In vitro MIC assay
The MIC of each compound was determined using a standard broth microdilution assay consistent with the guidelines of the Clinical Laboratory Standards Institute. Stock solutions of test compounds were diluted in a 2-fold series to achieve the desired concentrations. 
